Search Results

Colon Cancer Biologic therapy Search Results

Your search returned 30 record(s).
Page 1 of 3 | Next Page

Sort By:

Please visit our sponsors.

Important: Access to this information is subject to the full Cancer Monthly User Agreement .

We urge you to read this User Agreement. Below are some excerpts from this Agreement. These excerpts are provided for your convenience only and do not replace the full User Agreement:

Cancer Monthly does not provide medical or any other health care advice, diagnosis or treatment.
Cancer Monthly is provided for informational purposes only and is not a substitute for professional medical advice, examination, diagnosis or treatment.
You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to existing treatment.
You should not delay in seeking or disregard medical advice based on information in Cancer Monthly or the information below.
All the information available on the Cancer Monthly website including the information below is designed to be shared with your physician or other qualified healthcare professional
Medical information changes rapidly and while Cancer Monthly makes efforts to update its content, some information may be out of date.
No information contained in Cancer Monthly including the information below, should be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.

Again, your access to the information below is subject to the entire User Agreement.

	Survival:	Patients:	Toxicity:	Treatment:	Hospital:	Country:	Date:
1	52.9 months	colorectal (metastatic)	2	Biologic therapy Immunotherapy	Ospedale Civile di Avezzano	Italy	9/2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical controls, co

2	30.0 months	Metastatic colorectal cancer	4	Biologic therapy Chemotherapy	Vall d'Hebron University Hospital	Spain	11/2007
Treatment Details: Patients: This phase II study involved 62 patients with metastatic colorectal cancer. The median age was 65 years, ranging from 43 to 78. Thirty of these patients were men, and 13 were wo

3	26.0 months	Colorectal cancer with unresectable liver metastases	4	Biologic therapy Chemotherapy	Mayo Clinic and Foundation	United States	12/2005
Treatment Details: Patients: This Phase II study involved 42 patients with colorectal cancer with unresectable liver metastases. Twenty-four patients were men and eighteen were women. Eight patients had chem

4	23.1 months	Metastatic colorectal cancer	4	Biologic therapy Chemotherapy	Dana-Farber Cancer Institute	United States	10/2007
Treatment Details: Patients: This phase III study involved 430 patients with previously untreated metastatic colorectal cancer. These patients ranged in age from 20 to 87 years old. Treatment: Patients w

5	19.0 months	colorectal (untreated metastatic)	3	Biologic therapy Chemotherapy	University of North Carolina	United States	7/2006
Treatment Details: Patients: This trial involved a total of 305 patients with previously untreated metastatic colorectal cancer. Patients were divided into two groups � Group A with 151 patients and Group B w

6	18.2 months	metastatic colorectal cancer	4	Biologic therapy Chemotherapy	Centre Rene Gauducheau	France	1/2006
Treatment Details: Patients: This Phase II study involved 64 patients with metastatic colorectal cancer (49 patients had colon cancer and 15 patients had rectal cancer.) Thirty-six patients were men, and twen

7	18.0 months	Peritoneal carcinomatosis from colon adenocarcinoma	4	Biologic therapy Chemotherapy Surgery	University of Padova	Italy	6/2003
Treatment Details: Patients: This Phase II study involved 46 patients treated for peritoneal carcinomatosis from colon adenocarcinoma. Treatment: Thirty-four patients were treated with complete cytoreducti

8	16.3 months	colorectal (untreated metastatic)	3	Biologic therapy Chemotherapy	University of North Carolina	United States	7/2006
Treatment Details: Patients: This trial involved a total of 305 patients with previously untreated metastatic colorectal cancer. Patients were divided into two groups � Group A with 151 patients and Group B w

9	15.8 months	colorectal (metastatic)	4	Biologic therapy Chemotherapy	Hopital Tenon	France	1/2007
Treatment Details: Patients: This phase II study involved 42 patients with metastatic colorectal cancer. Twenty-four were men and 18 were women, and the median age was 60, ranging from 31-76. 67% had stage I

10	15.2 months	Advanced colorectal cancer	4	Biologic therapy Chemotherapy	Royal Marsden Hospital	United Kingdom	11/2005
Treatment Details: Patients: This Phase III study involved 630 patients with previously untreated metastatic colorectal cancer. The patients were randomized into two groups. Group B had 208 patients (149 men

Page 1 of 3\| Next Page

DISCLAIMER: The following is a summary of some of the terms & conditions for accessing the information on this website. It is provided for convenience only. For the full terms & conditions please click here. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional medical advice, examination, diagnosis or treatment. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. This website provides links to other websites for convenience only. Cancer Monthly is not responsible for the availability or content of these external websites, nor does Cancer Monthly endorse, warrant or guarantee the products, services or information described or offered at these other websites.